Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Trial of Maintenance Enzalutamide in CRPC

NCT06015321 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT06015321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06015321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Trial of Maintenance Enzalutamide in CRPC
Lead sponsor
Samsung Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
October 1, 2023
Completion date
April 30, 2026
Enrollment
51 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic adenocarcinoma